New gel injection could ease arthritic knees

NCT ID NCT07516457

Recruiting now Symptom relief Sponsor: Allegro NV/SA Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a single injection of Hydrogel OA 2% in 20 adults with knee osteoarthritis. The goal is to see if the gel is safe and tolerable over 13 weeks to 12 months. Participants must be 35–75 years old with a BMI between 20 and 35.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Hydrogel OA 2%

What this could lead to

If it works, this could provide a safe, single-injection option to ease knee osteoarthritis pain and improve joint function.

What could go wrong

This is a very small, early safety study with only 20 participants. It does not yet measure effectiveness, and the gel may not reduce pain or could cause side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEO ARTHRITIS OF THE KNEE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OSTEO ARTHRITIS OF THE KNEE

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

AZ Delta
RECRUITING

Roeselare, Belgium
AZ Monica
RECRUITING

Deurne, Belgium
AZ Sint Jan
RECRUITING

Bruges, Belgium